• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外显子组测序鉴定出与马凡综合征心血管表型极端表现相关的遗传变异。

Exome Sequencing Identifies Genetic Variants Associated with Extreme Manifestations of the Cardiovascular Phenotype in Marfan Syndrome.

机构信息

Doctorado en Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 8320000, Chile.

Servicio de Cirugía Cardiovascular, Instituto Nacional del Tórax, Santiago 7500808, Chile.

出版信息

Genes (Basel). 2022 Jun 8;13(6):1027. doi: 10.3390/genes13061027.

DOI:10.3390/genes13061027
PMID:35741789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9223058/
Abstract

Marfan Syndrome (MFS) is an autosomal dominant condition caused by variants in the fibrillin-1 () gene. Cardinal features of MFS include ectopia lentis (EL), musculoskeletal features and aortic root aneurysm and dissection. Although dissection of the ascending aorta is the main cause of mortality in MFS, the clinical course differs considerably in age of onset and severity, even among individuals who share the same causative variant, suggesting the existence of additional genetic variants that modify the severity of the cardiovascular phenotype in MFS. We recruited MFS patients and classified them into severe ( = 8) or mild aortic phenotype ( = 14) according to age of presentation of the first aorta-related incident. We used Exome Sequencing to identify the genetic variants associated with the severity of aortic manifestations and we performed linkage analysis where suitable. We found five genes associated with severe aortic phenotype and three genes that could be protective for this phenotype in MFS. These genes regulate components of the extracellular matrix, TGFβ pathway and other signaling pathways that are involved in the maintenance of the ECM or angiogenesis. Further studies will be required to understand the functional effect of these variants and explore novel, personalized risk management and, potentially, therapies for these patients.

摘要

马凡综合征(MFS)是一种常染色体显性遗传病,由原纤维蛋白 1(FBN1)基因突变引起。MFS 的主要特征包括晶状体异位(EL)、肌肉骨骼特征和主动脉根部瘤和夹层。尽管升主动脉夹层是 MFS 患者死亡的主要原因,但发病年龄和严重程度的临床病程差异很大,即使是携带相同致病变异的个体也是如此,这表明存在其他遗传变异,可修饰 MFS 心血管表型的严重程度。我们招募了 MFS 患者,并根据首次与主动脉相关的事件发生时的年龄将其分为严重(=8)或轻度主动脉表型(=14)。我们使用外显子组测序来确定与主动脉表现严重程度相关的遗传变异,并在合适的情况下进行连锁分析。我们发现了五个与严重主动脉表型相关的基因和三个可能对 MFS 中这种表型有保护作用的基因。这些基因调节细胞外基质的成分、TGFβ 途径和其他参与 ECM 维持或血管生成的信号通路。需要进一步研究这些变异的功能影响,并探索针对这些患者的新的个体化风险管理和潜在治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e965/9223058/c313fbac2b32/genes-13-01027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e965/9223058/c313fbac2b32/genes-13-01027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e965/9223058/c313fbac2b32/genes-13-01027-g001.jpg

相似文献

1
Exome Sequencing Identifies Genetic Variants Associated with Extreme Manifestations of the Cardiovascular Phenotype in Marfan Syndrome.外显子组测序鉴定出与马凡综合征心血管表型极端表现相关的遗传变异。
Genes (Basel). 2022 Jun 8;13(6):1027. doi: 10.3390/genes13061027.
2
Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.马凡综合征的心血管特征及其与基因型的关系。
Verh K Acad Geneeskd Belg. 2009;71(6):335-71.
3
Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome.原纤蛋白-1基因型与马凡综合征心血管受累严重程度之间的关系。
Heart. 2017 Nov;103(22):1795-1799. doi: 10.1136/heartjnl-2016-310631. Epub 2017 May 3.
4
Genotype and clinical phenotype of children with Marfan syndrome in Southeastern Anatolia.东南 Anatolia 地区马凡综合征患儿的基因型与临床表型。
Eur J Pediatr. 2024 Aug;183(8):3219-3232. doi: 10.1007/s00431-024-05579-3. Epub 2024 May 3.
5
Role of TGFBR1 and TGFBR2 genetic variants in Marfan syndrome.TGFBR1 和 TGFBR2 基因突变在马凡综合征中的作用。
J Vasc Surg. 2018 Jul;68(1):225-233.e5. doi: 10.1016/j.jvs.2017.04.071. Epub 2017 Aug 26.
6
Association of modifiers and other genetic factors explain Marfan syndrome clinical variability.修饰因子和其他遗传因素与马凡综合征的临床表现多样性相关。
Eur J Hum Genet. 2018 Dec;26(12):1759-1772. doi: 10.1038/s41431-018-0164-9. Epub 2018 Aug 7.
7
Marfan syndrome.马凡综合征。
Nat Rev Dis Primers. 2021 Sep 2;7(1):64. doi: 10.1038/s41572-021-00298-7.
8
Overcoming challenges associated with identifying FBN1 deep intronic variants through whole-genome sequencing.通过全基因组测序克服与鉴定 FBN1 深内含子变异相关的挑战。
J Clin Lab Anal. 2024 Jan;38(1-2):e25009. doi: 10.1002/jcla.25009. Epub 2024 Jan 17.
9
Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.对171例因疑似马凡综合征而转诊进行原纤维蛋白-1基因FBN1分子研究的患者进行基因型和表型分析。
Arch Intern Med. 2001 Nov 12;161(20):2447-54. doi: 10.1001/archinte.161.20.2447.
10
Pathogenic FBN1 variants in familial thoracic aortic aneurysms and dissections.家族性胸主动脉瘤和夹层中的致病性FBN1变异体。
Clin Genet. 2016 Jun;89(6):719-23. doi: 10.1111/cge.12702. Epub 2016 Jan 20.

引用本文的文献

1
Phenotypic Diversity of Marfan Syndrome.马凡综合征的表型多样性
JACC Adv. 2025 Aug 8;4(9):102051. doi: 10.1016/j.jacadv.2025.102051.

本文引用的文献

1
In-depth bioinformatic study of the cadherin 5 interactome in patients with thoracic aortic aneurysm unveils 8 novel biomarkers.深入研究胸主动脉瘤患者钙黏蛋白 5 相互作用组,揭示 8 个新的生物标志物。
Eur J Cardiothorac Surg. 2021 Dec 27;61(1):11-18. doi: 10.1093/ejcts/ezab338.
2
Regulation of SMC traction forces in human aortic thoracic aneurysms.调控人胸主动脉瘤中平滑肌细胞的牵引力。
Biomech Model Mechanobiol. 2021 Apr;20(2):717-731. doi: 10.1007/s10237-020-01412-6. Epub 2021 Jan 15.
3
The translation attenuating arginine-rich sequence in the extended signal peptide of the protein-tyrosine phosphatase PTPRJ/DEP1 is conserved in mammals.
蛋白质酪氨酸磷酸酶 PTPRJ/DEP1 延伸信号肽中的翻译衰减精氨酸丰富序列在哺乳动物中是保守的。
PLoS One. 2020 Dec 9;15(12):e0240498. doi: 10.1371/journal.pone.0240498. eCollection 2020.
4
The involvement of protein TNFSF18 in promoting p-STAT1 phosphorylation to induce coronary microcirculation disturbance in atherosclerotic mouse model.蛋白质TNFSF18在促进p-STAT1磷酸化以诱导动脉粥样硬化小鼠模型冠状动脉微循环紊乱中的作用。
Drug Dev Res. 2021 Feb;82(1):115-122. doi: 10.1002/ddr.21735. Epub 2020 Aug 21.
5
Is HSPG2 a modifier gene for Marfan syndrome?HSPG2 是否为马凡综合征的修饰基因?
Eur J Hum Genet. 2020 Sep;28(9):1292-1296. doi: 10.1038/s41431-020-0666-0. Epub 2020 Jun 8.
6
Candidate modifier genes for immune function in 22q11.2 deletion syndrome.22q11.2 缺失综合征中免疫功能的候选修饰基因。
Mol Genet Genomic Med. 2020 Jan;8(1):e1057. doi: 10.1002/mgg3.1057. Epub 2019 Dec 12.
7
The novel coronary artery disease risk gene JCAD/KIAA1462 promotes endothelial dysfunction and atherosclerosis.新型冠状动脉疾病风险基因 JCAD/KIAA1462 可促进血管内皮功能障碍和动脉粥样硬化。
Eur Heart J. 2019 Aug 1;40(29):2398-2408. doi: 10.1093/eurheartj/ehz303.
8
Targeting PPARα for the Treatment and Understanding of Cardiovascular Diseases.靶向过氧化物酶体增殖物激活受体α用于心血管疾病的治疗与理解
Cell Physiol Biochem. 2018;51(6):2760-2775. doi: 10.1159/000495969. Epub 2018 Dec 12.
9
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.STRING v11:具有增强覆盖范围的蛋白质-蛋白质相互作用网络,支持在全基因组实验数据集的功能发现。
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. doi: 10.1093/nar/gky1131.
10
Association of modifiers and other genetic factors explain Marfan syndrome clinical variability.修饰因子和其他遗传因素与马凡综合征的临床表现多样性相关。
Eur J Hum Genet. 2018 Dec;26(12):1759-1772. doi: 10.1038/s41431-018-0164-9. Epub 2018 Aug 7.